Skip to main content
. 2017 Mar;74:38–46. doi: 10.1016/j.ejca.2016.11.031

Fig. 1.

Fig. 1

CONSORT flow diagram of trial participants. *Three of the patients allocated to OxCapRT were actually given CarPacRT due to toxicities during induction chemotherapy.